Vaishali Pharma
VAISHALI · Pharma > Pharmaceuticals & Drugs · Chairman: Atul Vasani · MD: Atul Vasani · Listing date: Aug. 23, 2017 · Employees: 32 · Mumbai · http://www.vaishalipharma.com

Stock Price vs Company Growth
1d
0.0%
1w
0.0%
1m
11.8%
3m
29.9%
6m
45.0%
1y
60.3%
5y
52.8%
all
24.8%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 22 0%
17
24.9
Company Overview

Sales
99.2 Cr
Growth: 20.9%
Profit after Tax
1.09 Cr
Growth: 31.7%
Micro Cap
281 Cr
P/E: 360.2x
Industry P/E: 36.0x
Fundamentals

Sales (Cr) ₹ 99.2
Growth 20.9%
EBITDA 0.9%
P/S 2.8x
Dividend 0.0%
P/E 360.2x
Book Value ₹ 3.82
PEG Ratio 17.2x
ROE 2.4%
P/B 5.8x
Shareholding Pattern

Institutions
Samyag Broking Private Limited
1.31 %
Promoters
Atul Arvindbhai Vasani
51.63 %
Jagruti Atul Vasani
4.55 %
Bharti Kiritkumar Tolia
1.57 %
Vaishali A Vasani
1.43 %
Punita Kaushik Gandhi
0.04 %
Others
Increase    Decrease    No change
Company Profile Detailed

The company is a pharmaceutical company, dealing in pharmaceutical formulations, APIs, surgical products, veterinary supplements. It is operating both in domestic and export markets. In domestic markets, it is majorly into trading of APIs whereas in export markets, it is into trading and marketing of APIs, formulations, surgical products and others.
Investors (69)